NO
My post was based on the announcement about Trophon 2. You will recall that NAN got FDA approval much quicker than planned for and resulted in marketing difficulties. I was thinking that FDA etc would be quick to rush NAN's product through into the healthcare sector and upset NAN's plans.
WOW NAN, page-4
Add NAN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.87 |
Change
-0.100(3.37%) |
Mkt cap ! $869.5M | |||
| Open | High | Low | Value | Volume |
| $2.90 | $2.93 | $2.87 | $1.650M | 571.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 24770 | $2.86 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.88 | 2390 | 1 |
View Market Depth
| Last trade - 16.10pm 24/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$2.88 |
Change
-0.100 ( 3.25 %) |
||||
| Open | High | Low | Volume | ||
| $2.93 | $2.93 | $2.87 | 171198 | ||
| Last updated 15.59pm 24/05/2024 ? | |||||
| NAN (ASX) Chart |